Protara Therapeutics, Inc. Common Stock TARA
HEALTHCARE · BIOTECHNOLOGYi
Market datapartial · fetched 2026-11-13T01:25:59.691Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-02-19
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:00:01.657796107Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T01:25:57.894851+00:00
Protara Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | 3.97 | 110.8% | 74.4% | |||
| 40Δ | 3.68 | 111.1% | 64.8% | |||
| 45Δ | 3.40 | 111.5% | 55.2% | |||
| 50Δ | 3.11 | 111.8% | 45.5% | |||
| 55Δ | 2.82 | 112.1% | 35.9% | |||
| 60Δ | 2.54 | 112.5% | 26.3% | |||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 3.97
- IV
- 110.8%
- B/E move
- 74.4%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 3.68
- IV
- 111.1%
- B/E move
- 64.8%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 3.40
- IV
- 111.5%
- B/E move
- 55.2%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 3.11
- IV
- 111.8%
- B/E move
- 45.5%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 2.82
- IV
- 112.1%
- B/E move
- 35.9%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 2.54
- IV
- 112.5%
- B/E move
- 26.3%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 160.82% | |
| 151.72% | |
| 152.47% |
Biotechnology
TARS
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions.…
More →TECH
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is…
More →TECX
Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel therapies for patients…
More →TENX
Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the…
More →TGTX
Description unavailable
More →TNGX
Description unavailable
More →